(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

OHC OSANG HEALTHCARE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

OHC OSANG HEALTHCARE

ST13

US500000088500869

Class

5

Filing

88500869

Registration

6269246

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

32

Latest update

02/17/2026

Trademark type

Combined

Nice classes

5

Filing date

07/04/2019

Registration date

02/16/2021

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

02/16/2021

Last transaction

02/17/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use, Foreign priority

Drawing code

5

Owner type

16

Owner location

Anyang-si, Gyeonggi-do, KR

Examiner

FALK, JONATHAN ROBERT

Law office

M20

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the stylized letters "OHC" and below the wording "OSANG HEALTHCARE".

Holders and representatives

Holders

OSANG HEALTHCARE CO., LTD.

Representatives

John Alumit ALUMIT IP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Medical diagnostic test strips for diabetics; Medical diagnostic test reagents for diabetics; medical diagnostic test kit comprised of medical diagnostic reagents and assays for testing viral infections; Diagnostic test reagents for veterinary purposes; Medical diagnostic reagents for use in genetic diseases testing; Medical diagnostic test reagents for use in genetic diseases testing; Medical diagnostic strips for glycated hemoglobin; Medical diagnostic test reagents for blood glucose; Medical diagnostic strips for liver disease; Medical diagnostic test reagents for liver disease; Medical diagnostic test reagents for glycated hemoglobin; Reagent paper for medical purposes; Medical diagnostic strips for cardiac disease; Medical diagnostic test reagents for cardiac disease; Medical diagnostic test reagents for cancerous diseases; Medical diagnostic strips for cancerous diseases; Medical diagnostic strips; Diagnostic test reagents for medical purposes; Diagnostic agents for medical use; Medical diagnostic test reagents for cholesterol; Medical diagnostic strips for cholesterol; Medical diagnostic strips for blood glucose; Reagents for clinical medical tests; Diagnostic kit comprised of medical diagnostic reagents and assays for testing contagious infection symptoms

Publications

History of USPTO decisions and trademark events.

32 publications found

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

02/16/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

02/16/2021

DP1B

1(B) BASIS DELETED; PROCEED TO REGISTRATION

01/13/2021

IUCN

NOTICE OF ALLOWANCE CANCELLED

12/22/2020

D1BR

TEAS DELETE 1(B) BASIS RECEIVED

12/22/2020

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

12/22/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

10/27/2020

PUBO

PUBLISHED FOR OPPOSITION

10/27/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

10/07/2020

FIXD

ELECTRONIC RECORD REVIEW COMPLETE

09/22/2020

ERRR

ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED

09/18/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/11/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

08/18/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/18/2020

ALIE

ASSIGNED TO LIE

08/16/2020

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

07/29/2020

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

03/11/2020

GNSL

LETTER OF SUSPENSION E-MAILED

03/11/2020

CNSL

SUSPENSION LETTER WRITTEN

03/11/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/10/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/09/2020

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

03/09/2020

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

09/30/2019

GNRT

NON-FINAL ACTION E-MAILED

09/30/2019

CNRT

NON-FINAL ACTION WRITTEN

09/30/2019

DOCK

ASSIGNED TO EXAMINER

09/23/2019

DPCC

DIVISIONAL PROCESSING COMPLETE

09/03/2019

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

08/27/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/13/2019

DRRR

DIVISIONAL REQUEST RECEIVED

07/11/2019

ERTD

TEAS REQUEST TO DIVIDE RECEIVED

07/11/2019

NWAP

NEW APPLICATION ENTERED

07/08/2019

Continuous trademark protection

Get notified about every new filing that threatens OHC OSANG HEALTHCARE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.